Fourteen out of 15 severe #COVID-19 patients who were treated in a clinical study of the drug #TriCor (fenofibrate) didn’t require oxygen support within a week of treatment, and were released from the hospital.https://t.co/dQx1HtCLab

— The Jerusalem Post (@Jerusalem_Post) August 26, 2021

Interesting, I’d like to see peer reviewed large scale double blind trials.